期刊文献+

多发性硬化34例临床分析 被引量:5

多发性硬化34例临床分析
下载PDF
导出
摘要 目的探讨多发性硬化(MS)的临床特点。方法从一般临床资料、病变部位影像学等方面对MS进行分析。结果34例MS病例中,中青年女性多见,临床表现复杂。病程中多出现缓解复发,仅靠临床表现诊断较难,应结合磁共振成像、电生理、脑脊液检查等。糖皮质激素及免疫抑制剂治疗有效。结论根据临床表现,结合辅助检查可明显提高MS的确诊率。 Objective To study the clinical features of multiple sclerosis. Methods We have retrospectively studied the cases on general clinic, lesion locations, imaging. Results Among 34 MS cases, MS mainly affected young and middle-aged women, the clinical manifestations were complex. Alleviation and recurrence happened alternately during the course. Diagnosis was difficult based on clinical manifestations only. Combination of magnetic resonance imaging, electrophysiology and cerebrospinal fluid examination contribute to the diagnosis. Glucocorticoid treatment and immunosuppressive agents were effective. Conclusion According to clinical manifestations, it combined with examination may improve the diagnosis rate of MS.
出处 《当代医学》 2009年第30期66-67,共2页 Contemporary Medicine
关键词 多发性硬化 磁共振成像 临床分析 Multiple sclerosis Magnetic resonance imaging Clinical analysis
  • 相关文献

参考文献3

二级参考文献31

  • 1蔡兴秋,赵翕平,邓荣昆.多发性硬化的发作性症状[J].中华神经科杂志,1996,29(1):26-28. 被引量:9
  • 2赵顺珍,赵薛旭.早发性多发性硬化32例[J].实用儿科临床杂志,1997,12(1):10-13. 被引量:3
  • 3徐章纯 王维治.多发性硬化症151例临床分析[J].中华神经精神科杂志,1984,17(6):337-381.
  • 4赵葆洵 刘秀琴 等.我国多发性硬化的临床特点[J].中华神经精神科杂志,1979,12:169-169.
  • 5[1]Zang YC, Halder JB, Samanta AK, et al. Regulation of chemokine receptor CCR5 and production of RANTES and MIP-1alpha by interferon-beta[J]. J Neuroimmunol, 2001,112(1-2):174-180.
  • 6[2]Lopez E, Racadot E, Bataillard M,et al. Interferon gamma, IL2, IL4, IL10 and TNFalpha secretions in multiple sclerosis patients treated with an anti-CD4 monoclonal antibody[J]. Autoimmunity, 1999,29(2):87-92.
  • 7[3]Coles AJ, Wing MG, Molyneux P, et al. Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis[J]. Ann Neurol, 1999,46(3):296-304.
  • 8[4]Jonathan L Carter, Scottsdale AZ, Mark Agius, et al. A placebo-controlled phamacodynamic pharmacokintic tolerability and safety study of three doses of intravenous natilizumab in multiple sclerosis[J]. Neurology, 2000,(supple 3):A259.
  • 9[5]Kanwar JR, Harrison JE, Wang D,et al. Beta7 integrins contribute to demyelinating disease of the central nervous system[J]. J Neuroimmunol, 2000,103(2):146-152.
  • 10[6]Rottman JB, Slavin AJ, Silva R, et al. Leukocyterecruitment during onset of experimental allergicencephalomyelitis is CCR1 dependent[J]. Eur J Immunol, 2000,30(8):2372-2377.

共引文献62

同被引文献47

  • 1刘呜,谢鹏.神经内科学[M].北京:人民卫生出版社,2008:277.
  • 2AI - Shamm S, Rawoot P, Azizieh F, et al. Th1/Th2 cytokine pattems and clinical proifles during and after pregnancy in women with multiple sclerosis [ J ]. NeurolSci, 2004,222(12) :21-27.
  • 3Petereit HF, Richter N, Pukrop R, et al. Interferon gamma production in blood lymphocytes correlates with disability score inmuhiple sclerosis patients [ J ]. Mutt - scler,2000,6( 1 ) : 19-23.
  • 4Zivadinov R,Rudick RA,DeMasi R,et al.Effects of Ⅳ methylperdniolone on brain atrophy in relapsing-remitting MS[J].Neurology,2001,57(7):1239-1247.
  • 5Tullman MJ,Lublin FD,Miller AE.Immunotherapy of multiplesclerosis current practice and future directions[J].J Rehabil Res Dev,2002,39(2):273-285.
  • 6Kieseier BC,Hartung HP.Current disease modifying therapies in multiple sclerosis[J].2003 Semin Neurol,2003,23:133-146.
  • 7Secondary Progressive Efficacy Clinical Trial of Recombinant Interferon-beta-la in MS(SPECTRIMS)Study Group.Randomized controlled trial of interferon-beta-la in secondary progressive MS clinical results[J],Neurology,2001,56(11):1496-1504.
  • 8Coles AJ.Neutralising antibodies to the beta interferons[J].J Neurol Neurosurg Psychiatry,2002,73(2):110-111.
  • 9Coyle P.Results of comparative efficacy trial using two formulations of interferon beta-la in RRMS[J].J Rehabil Res Dev,2002,39(2):211-224.
  • 10Kita M,Pelletier D,Goodkin D,et al.A phasell trial of mitoxantrone in patients with primary progressive multiple sclerosis[J].Neurology,2001,56(Supp 13):149-150.

引证文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部